Mithra Pharmaceuticals Sa Stock Net Income
| MITPFDelisted Stock | USD 6.75 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mithra Pharmaceuticals, as well as the relationship between them.
Mithra Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mithra Pharmaceuticals' valuation are provided below:Mithra Pharmaceuticals SA does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Mithra |
Search Suggestions
| MIT | Mason Industrial Technology | CompanyDelisted |
| MITT-PA | AG Mortgage Investment | Company |
| MITN | AG Mortgage Investment | Company |
| MITDX | Massachusetts Investors Trust | Mutual Fund |
| MITX | MITX | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Mithra Pharmaceuticals SA reported net income of (116.88 Million). This is 134.25% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 120.47% higher than that of the company.
Mithra Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mithra Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Mithra Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Mithra Pharmaceuticals by comparing valuation metrics of similar companies.Mithra Pharmaceuticals is currently under evaluation in net income category among its peers.
Mithra Fundamentals
| Return On Equity | -1.39 | |||
| Return On Asset | -0.11 | |||
| Operating Margin | (3.60) % | |||
| Current Valuation | 425.3 M | |||
| Shares Outstanding | 56.31 M | |||
| Shares Owned By Insiders | 32.32 % | |||
| Shares Owned By Institutions | 15.87 % | |||
| Price To Book | 9.76 X | |||
| Price To Sales | 17.08 X | |||
| Revenue | 22.67 M | |||
| Gross Profit | 6.94 M | |||
| EBITDA | (101.58 M) | |||
| Net Income | (116.88 M) | |||
| Cash And Equivalents | 29.3 M | |||
| Cash Per Share | 0.59 X | |||
| Total Debt | 125.24 M | |||
| Debt To Equity | 9.62 % | |||
| Current Ratio | 0.80 X | |||
| Book Value Per Share | 0.72 X | |||
| Cash Flow From Operations | (74.39 M) | |||
| Earnings Per Share | (2.82) X | |||
| Number Of Employees | 300 | |||
| Beta | 0.49 | |||
| Market Capitalization | 380.13 M | |||
| Total Asset | 421.92 M | |||
| Z Score | 1.8 | |||
| Net Asset | 421.92 M |
About Mithra Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mithra Pharmaceuticals SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mithra Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mithra Pharmaceuticals SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Mithra Pink Sheet
If you are still planning to invest in Mithra Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mithra Pharmaceuticals' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |